Readmissions July 2017 Pharmacy Roundtable Office Hour- - - PowerPoint PPT Presentation

readmissions
SMART_READER_LITE
LIVE PREVIEW

Readmissions July 2017 Pharmacy Roundtable Office Hour- - - PowerPoint PPT Presentation

An Initiative of the Florida Hospital Association Hospital Improvement Innovation Network Pharmacy Roundtable: Reducing ADE, C. diff and Readmissions July 2017 Pharmacy Roundtable Office Hour- Interactive Agenda Hosted by Mission To Care


slide-1
SLIDE 1

An Initiative of the Florida Hospital Association

Hospital Improvement Innovation Network Pharmacy Roundtable: Reducing ADE, C. diff and Readmissions July 2017

slide-2
SLIDE 2

Pharmacy Roundtable – Office Hour- Interactive Agenda Hosted by Mission To Care (MTC) FHA (Hospital Improvement Innovation Network) Facilitated by:

Phyllis Byles-FHA Quality Improvement Advisor Scott King-PharmD-Orlando Health Dr. P. Phillips Hospital

slide-3
SLIDE 3

Agenda

  • History of Partnership for Patients

(PfP)/pharmacy roundtable

  • Successes-quality and financial
  • Status of work for HIIN
  • Dialogue or Next Steps-how do we move

forward?

  • What can MTC do for you?
  • Survey
slide-4
SLIDE 4

History for PfP

  • Provided by the legislation in ACA
  • Intent to reduce harm and cost in healthcare
  • Pharmacists were identified as key partners
  • Pharmacy roundtable initiated in 2013
  • MTC advocates for all providers and needs

pharmacists involved in key core measures

  • Supports peer learning and small tests of change
slide-5
SLIDE 5

FHA HEN Results: 2012-2016

Prevented 31,342 cases of harm Avoided $198 million in healthcare costs

slide-6
SLIDE 6

Where We are Going- HIIN

partnershipforpatients.cms.gov

GOALS:

20%

Overall Reduction in Hospital Acquired Conditions (baseline 2014)

12%

Reduction in 30-Day Readmissions (baseline 2014)

“America’s hospitals embrace the ambitious new goals CMS has proposed,” said Rick Pollack, president and CEO of the American Hospital Association (AHA). “The vast majority of the nation’s 5,000 hospitals were involved in the successful pursuit of the initial Partnership for Patients aims. Our goal is to get to zero incidents. AHA and our members intend to keep an unrelenting focus on providing better, safer care to our patients -- working in close partnership with the federal government and with each

  • ther.”

AS WE MOVE FORWARD-- LET’S FOCUS ON WHAT’S GOING WELL FOR US!!!!!!

slide-7
SLIDE 7

ADEs – Excessive Anticoagulation

BL 10/16 11/16 12/16 01/17 02/17 03/17 04/17 FL Rate 3.72 2.40 2.07 3.08 2.71 2.80 2.69 2.31 HRET HIIN Rate 3.67 4.27 4.07 4.42 4.22 3.51 2.81 2.84 # FL Reporting 67 73 72 73 73 73 72 59 #HRET HIIN Reporting 1,148 1,214 1,218 1,215 1,238 1,235 1,165 971 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50

Rate per 100

Source: Comprehensive Data System, July 6, 2017

slide-8
SLIDE 8

ADEs – Hypoglycemia

BL 10/16 11/16 12/16 01/17 02/17 03/17 04/17 FL Rate 5.25 2.88 2.82 3.01 2.69 2.79 3.27 2.84 HRET HIIN Rate 4.07 3.73 3.70 3.59 3.84 4.05 4.25 4.07 # FL Reporting 60 63 62 63 62 62 60 52 #HRET HIIN Reporting 1,090 1,150 1,155 1,152 1,174 1,166 1,108 937 0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00

Rate per 100

Source: Comprehensive Data System, July 6, 2017

slide-9
SLIDE 9

ADEs – Opioids

BL 10/16 11/16 12/16 01/17 02/17 03/17 04/17 FL Rate 0.52 0.45 0.48 0.46 0.45 0.45 0.48 0.47 HRET HIIN Rate 0.48 0.45 0.46 0.48 0.49 0.52 0.52 0.54 # FL Reporting 66 71 70 71 68 66 63 55 #HRET HIIN Reporting 1,124 1,168 1,173 1,168 1,187 1,178 1,113 949 0.00 0.20 0.40 0.60 0.80

Rate per 100

Source: Comprehensive Data System, July 6, 2017

slide-10
SLIDE 10
  • C. Difficile

BL 10/16 11/16 12/16 01/17 02/17 03/17 04/17 FL Rate 6.95 5.05 5.43 5.15 5.03 5.05 4.67 4.32 HRET HIIN Rate 6.14 6.12 6.12 5.78 6.05 5.47 5.26 4.91 # FL Reporting 90 90 90 90 89 89 87 76 #HRET HIIN Reporting 1,506 1,552 1,551 1,554 1,530 1,525 1,471 1,186 0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00

Rate per 10,000

Source: Comprehensive Data System, July 6, 2017

slide-11
SLIDE 11

Falls

BL 10/16 11/16 12/16 01/17 02/17 03/17 04/17 FL Rate 0.56 0.55 0.62 0.59 0.57 0.59 0.57 0.52 HRET HIIN Rate 0.66 0.75 0.75 0.81 0.83 0.84 0.84 1.00 # FL Reporting 87 83 84 84 85 84 83 70 #HRET HIIN Reporting 1,435 1,462 1,461 1,458 1,451 1,430 1,339 1,019 0.00 0.25 0.50 0.75 1.00 1.25 1.50

Rate per 1,000

Source: Comprehensive Data System, July 6, 2017

slide-12
SLIDE 12

Readmissions – 30 Days, All Cause

BL 10/16 11/16 12/16 01/17 02/17 03/17 FL Rate 10.67 9.97 10.01 9.61 9.83 9.72 9.40 HRET HIIN Rate 8.77 7.70 7.74 7.61 8.44 8.13 8.05 # FL Reporting 86 82 82 82 83 83 81 #HRET HIIN Reporting 1,412 1,433 1,433 1,439 1,367 1,230 1,002 0.0 2.0 4.0 6.0 8.0 10.0 12.0 14.0

Rate per 100

Source: Comprehensive Data System, July 6, 2017

slide-13
SLIDE 13

Readmissions – Medicare, All Cause

BL 10/16 11/16 12/16 01/17 02/17 03/17 FL Rate 13.43 12.33 12.33 11.35 12.09 12.00 11.60 HRET HIIN Rate 11.74 9.98 10.06 9.81 10.67 10.65 10.59 # FL Reporting 57 68 68 70 69 68 65 #HRET HIIN Reporting 1,054 1,267 1,265 1,276 1,199 1,064 852 0.0 2.0 4.0 6.0 8.0 10.0 12.0 14.0 16.0

Rate per 100

Source: Comprehensive Data System, July 6, 2017

slide-14
SLIDE 14

Florida Medicare Readmissions Within 30 Days—2015 (cont.)

14

Of the 54,512 readmissions within 7 days, 16,246 (29.8%) readmissions were for beneficiaries who were on High Risk Medications (HRMs).

That is almost 3 out of every 10 readmissions!

slide-15
SLIDE 15

30-Day Readmissions Among Medicare FFS Beneficiaries on HRMs in Florida—2015

15

30-Day All-Cause Readmission Rate

19.6%

30-Day HRM Readmission Rate

23.7%

  • Readmissions among beneficiaries on HRMs are

much more frequent than the general population, suggesting ample opportunity for improvement.

  • Percent of 30-day readmits with an anticoagulant
  • r diabetes agent ADE are much higher than the

percent of readmits with an opioid ADE.

slide-16
SLIDE 16

Financial Incentives for Strong Quality Processes

16

  • 2.00%
  • 2.00%
  • 2.00%
  • 2.00%
  • 2.00%
  • 2.00%
  • 2.00%
  • 2.00%
  • 1.00%
  • 1.25%
  • 1.50%
  • 1.75%
  • 2.00%
  • 2.00%
  • 1.00%
  • 2.00%
  • 3.00%
  • 3.00%
  • 3.00%
  • 3.00%
  • 1.00%
  • 1.00%
  • 1.00%
  • 1.00%
  • 9%
  • 8%
  • 7%
  • 6%
  • 5%
  • 4%
  • 3%
  • 2%
  • 1%

0% 2011 2012 2013 2014 2015 2016 2017 2018 PERCENT PAYMENT REDUCTION

IQR VBP Readmission Reduction HACS

National health expenditures total $3.4 Trillion-in hospital care=$1.1 Trillion (2016)

slide-17
SLIDE 17

2017 Legislative Session

  • Florida Medicaid hospital funding was reduced by $200

million in general revenue, which equals $521 million with the federal share. The reduction includes:

– A $108.4 million reduction to the diagnosis related group (DRG) base rate. This 5-percent reduction is less than the 7-percent rate cut initially proposed. – A $412.6 million reduction in hospital rate enhancements, also known as “add-on” payments. This is less than the $499.5 million reduction initially proposed.

slide-18
SLIDE 18

New Legislation Impacting Hospitals and Pharmacists

  • In 2017 legislation passed requiring hospital emergency

departments to develop best practices around drug overdose prevention

  • FHA is working with FCEP to draft guidelines and documents

that will meet the intent of the legislation

  • There is concern on the part of ED providers to support

appropriate/adequate medical management treatment resources

  • Opioid management and drug addictions are primary issues

and have wide ranging impact in our Florida communities

  • This is a place where the HIIN pharmacists can have a

significant role and contribution!

slide-19
SLIDE 19

Topics and Questions for participants:

  • A. Is opioid safety a concern in your community? Do you

have a best practice/policy in place for patients with addictions seen in your ED?

  • B. What is your hand hygiene policy? Is it effective?
  • C. Is data collection for hypoglycemia accurate?
  • D. How is D/C med rec done in your facility?
  • E. Is your hospital model of care inclusive of

pharmacists?

  • F. Are there barriers that MTC can help resolve?
  • G. What can MTC offer to you specifically for your

hospital needs?

slide-20
SLIDE 20

More Discussion…….

  • 1. Does your organization support/perform pharmacist-led med

rec and med therapy review?

  • 2. Do you have bedside delivery of meds prior to discharge?
  • 3. Do you have pharmacist-led discharge med counseling?
  • 4. Describe your hospital post-discharge follow up
  • 5. Describe your medication therapy management model
  • 6. How do you accomplish a comprehensive medication

history?

  • 7. Of utmost interest to MTC—how are transfers to ALF, SNFs

different than discharges home? What is the pharmacist role?

slide-21
SLIDE 21

Let’s Prioritize Next Steps

  • Results from chat box
  • MTC needs your help with guidelines for

the ED best practices for overdose legislation

  • MTC wants to improve transfer

documentation and communication. Who can help us?

slide-22
SLIDE 22

Next Pharmacy Roundtable-August 9th-1100

  • Memorial Hospital Pembroke- Jon Carlo C.

Francisco, Pharm.D., BCPS, Clinical Specialist – Infectious Disease, Antimicrobial Stewardship Pharmacist

  • Please plan to join us for this very interesting

presentation